Sinopharm Tech Holdings (HKSE:08156) Short-Term Debt & Capital Lease Obligation : HK$5.88 Mil (As of Dec. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Sinopharm Tech Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$5.88 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Sinopharm Tech Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$0.15 Mil.

Sinopharm Tech Holdings Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Sinopharm Tech Holdings's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Tech Holdings Short-Term Debt & Capital Lease Obligation Chart

Sinopharm Tech Holdings Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Short-Term Debt & Capital Lease Obligation

Get a 7-Day Free Trial

109.66

104.45

45.93

53.00

72.60

Sinopharm Tech Holdings Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
Short-Term Debt & Capital Lease Obligation	Get a 7-Day Free Trial															53.00	-	10.00	72.60	5.88

Sinopharm Tech Holdings Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Sinopharm Tech Holdings Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinopharm Tech Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » Short-Term Debt & Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18th Floor, Ruttonjee House, Hong Kong Central, Hong Kong, HKG

Website

https://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Internet Plus services; Supply chain services; and Manufacturing and distribution of personal protective equipment. It generates maximum revenue from Supply chain services segment, which includes provision of supply chain management, data analysis and related services and trading of related goods, and trading of medial and related products. Geographically, it derives a majority of revenue from Hong Kong.

Executives

Chiu Sin Nang Kenny	2201 Interest of corporation controlled by you
Creative Big Limited	2101 Beneficial owner
Integrated Asset Management (asia) Limited	2101 Beneficial owner
Yam Tak Cheung	2201 Interest of corporation controlled by you
Quantum Worldwide Investment Limited	2101 Beneficial owner
Best Frontier Investments Limited
Chan Kin Ho Philip	2201 Interest of corporation controlled by you
Lam Yui Keung	2201 Interest of corporation controlled by you
Sinopharm Traditional Chinese Medicine Overseas Holdings Limited	2101 Beneficial owner
Main Key Investments Limited	2201 Interest of corporation controlled by you
Guo Lei	2201 Interest of corporation controlled by you
Chan Tung Mei	2202 Interest of your spouse
Cheung Kwai Lan	2201 Interest of corporation controlled by you
Tse Siu Hoi	2101 Beneficial owner
Gam Star China Equity (a Sub-fund Of Gam Star Fund P.l.c.)	2102 Investment manager

Sinopharm Tech Holdings Headlines

No Headlines